USPTO serial 79097803
Reviewed by CopyMark Law Group
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Pharma Intelligence U.K. Limited
GB
GB
LONDON WIT 3JH, GB
LONDON WIT 3JH, GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright Epstein Drangel LLP60 East 42nd Street, Suite 1250New York, NY 10165UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable scientific and medical data via the internet; [ prerecorded magnetic data carriers and recording discs in relation to pharmaceutical technology, biotechnology, medical devices and diagnostics; computer software for use in database management; downloadable computer software for use in database management; ] electronic publications, namely, reports [ and manuals ] featuring information in relation to pharmaceutical technology, biotechnology, medical devices and diagnostics; downloadable electronic publications in the nature of reports, articles, journals, magazines, [ bulletins ] and newsletters in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics provided on-line from databases or the internet; [ computers; computer hardware; electronic and electromechanical peripheral apparatus, all for use with computers; ] digital media, namely, videos, [ CDs, DVDs, ] downloadable audio and video files, [ volatile storage and non-volatile storage in the form of pre-recorded digital media ] featuring information on pharmaceutical technology, biotechnology, medical devices and diagnostics [ ; educational software featuring instruction on computer software; apparatus for recording, transmission, processing and reproduction of sound, images or data ] | ACTIVE | — |
| 016 | [ Paper, cardboard and goods made from these materials, not included in other classes, namely, letterheads, envelopes, magazine paper, notepaper, notebooks, banners and business cards; ] [ printed matter, namely, reports, journals, articles, magazines, ] [ books, newspapers, news bulletins, ] [ newsletters and brochures in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics; printed matter, namely, reports, journals, articles, magazines, ] [ books, newspapers, news bulletins, ] [ newsletters and brochures in the field of computer software and programmes; instructional and teaching materials except apparatus, namely, journals, articles, newsletters ] [ and seminar notes ] [ in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics ] [ ; printers' type; printing blocks ] | SECTION 71 - CANCELLED | — |
| 041 | [ Education, namely, courses, classes, lectures, seminars, workshops, tutoring, mentoring and career counseling in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics; providing of training in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics; entertainment and recreational services, namely, arranging and conducting of recreational activities, sporting and cultural events, training and educational conferences, courses, seminars and exhibitions in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics; publishing of books and reviews;] publishing of electronic publications; providing current events news and information via a global computer network; providing a website featuring non-downloadable electronic publications in the nature of [letters,] magazines, journals, articles, [ books, newspapers, ] news bulletins and brochures in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics; providing information relating to the aforesaid services; providing information relating to the aforesaid services on-line | ACTIVE | — |
| 042 | [ Scientific and technological services and research and design relating thereto in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics; industrial research services in the field of pharmaceutical technology, biotechnology, medical devices and diagnostics; ] provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services; provision of on-line information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services; [ design and development of computer hardware and software; design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software design services; consultancy, design, testing, research and advisory services, all relating to computing and computer programming; website design services; computer programming; computer systems analysis; computer timesharing services; research and development of computer hardware and software; technological consultation in the technology field of computer hardware systems; rental and leasing of computers; computer rental and updating of computer software; computer software design; hosting of websites; ] hosting of digital content, namely, online journals and blogs [ ; computer technology support services, namely, help desk services; technical support services relating to computer hardware, computer software, computer networks and the Internet; computer network design services; computer network design for others, namely, on-line services for enhancing the performance and function of electronic communication; database design and development; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services relating to all the aforesaid services provided on-line ] | ACTIVE | — |
| 044 | [ Medical services; advisory medical services and ] the provision of medical information; [ dentistry services; advisory services and the provision of information relating to dentistry; advisory services and ] the provision of information relating to health; [ consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals, and locations following the administration of chemical, biological radiological or nuclear materials; ] providing medical information, [ consultancy and advisory services ] in the field of pharmaceuticals; medical information in the field of pharmaceuticals; [ dispensing of pharmaceuticals; veterinary services; medical diagnostic testing, ] monitoring and reporting services; medical information services, namely, reporting of clinical testing results [ ; medical analysis services; medical testing services; surgical treatment services; advisory services and the provision of medical information relating to surgery, advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services relating to all the aforesaid services provided on-line ] | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 24, 2025 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 23, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 23, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 17, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 4, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 17, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 17, 2024 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Sep 16, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 21, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 11, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jun 25, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 22, 2021 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jul 24, 2020 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 15, 2020 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 15, 2020 | INPC | INVALIDATION PROCESSED | — |
| May 7, 2020 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 7, 2019 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 7, 2019 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jul 9, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 20, 2019 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 25, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 8, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 12, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 26, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 26, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 25, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 25, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 17, 2013 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 5, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 20, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 31, 2013 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 1, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 1, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 14, 2012 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 12, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 12, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 12, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 28, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 28, 2012 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 26, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 20, 2012 | ALIE | ASSIGNED TO LIE | — |
| Nov 3, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 3, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 17, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 16, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 12, 2012 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Sep 25, 2012 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Jul 14, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 6, 2012 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jun 4, 2012 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| May 4, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 26, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2012 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Mar 27, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 17, 2012 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 17, 2012 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 17, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 14, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 27, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 27, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 22, 2011 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 7, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 29, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 29, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 29, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 28, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 27, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 24, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 23, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |